Hyderabad: BioAsia, a two-day Life Sciences and Health Tech symposium, will be held virtually starting February 24.
BioAsia is a global platform for various stakeholders, including biotech and biopharma companies, research institutions, academia, investors, service providers, policymakers, and regulators. It is the annual flagship event of the Telangana government and has emerged as a global platform for various stakeholders, including biotech and biopharma companies, research institutions, academia, investors, service providers, and policymakers and regulators.
The topic this year is 'Future Ready,' and it will focus on studying many facets of the Life Sciences business, including taking stock of accomplishments made and competencies needed to power future growth, according to the organisers.
"Hyderabad has solidified its status as the country's life sciences centre and the world's vaccine capital." "BioAsia has been a vital part of this incredible growth storey and continues to help us demonstrate the prowess of Hyderabad in particular and India in general," said Industries and Information Technology Minister K. T. Rama Rao, who invited stakeholders from all over the world to the event.
Pharma and biotech companies, CROs, CMOs, CDMOs, biotech start-ups, academic institutions, scientists and researchers, politicians, and regulatory experts from around the world will gather to analyse the industry's current state and discuss imperatives for future growth at the conference. The event will include a number of panels discussing the future of Life Sciences in the wake of the epidemic, as well as the areas on which the industry should focus in order to battle future pandemics, according to the organisers.
BioAsia 2022 will place a premium on the industry's future readiness
This year's Republic Day will be celebrated with drones show and laser show
Himachal Pradesh's foundation day today, find out how it got statehood